|
DE2615061A1
(de)
|
1976-04-05 |
1977-10-06 |
Wolfgang Dr Med Wagner |
Injektionsverfahren und -vorrichtungen
|
|
US4252159A
(en)
|
1979-04-02 |
1981-02-24 |
Maki Eugene B |
Dosage device
|
|
JPS60172925A
(ja)
|
1984-02-17 |
1985-09-06 |
Kao Corp |
胆石溶解剤
|
|
JPS6115809A
(ja)
|
1984-06-29 |
1986-01-23 |
Lion Corp |
細胞賦活剤
|
|
DE3501534A1
(de)
|
1984-09-22 |
1986-05-15 |
Walter Ing.(grad.) 7758 Meersburg Holzer |
Verfahren und vorrichtung zum dosieren von insulin oder aehnlichen langzeitmedikamenten
|
|
JPS6212716A
(ja)
|
1985-07-11 |
1987-01-21 |
Nippon Oil & Fats Co Ltd |
制がん剤
|
|
JPH0672142B2
(ja)
|
1986-10-15 |
1994-09-14 |
コニカ株式会社 |
４−アミノ−１，２，４−トリアゾリン−５−チオン系化合物の製造方法
|
|
DE3875075D1
(de)
|
1987-11-25 |
1992-11-05 |
Siemens Ag |
Dosiergeraet zum gesteuerten injizieren von fluessigkeiten aus einem vorratsbehaelter in einen organismus.
|
|
EP0569618B1
(de)
|
1992-05-12 |
1997-01-02 |
Siemens-Elema AB |
Dosiergerät zur gesteuerten Abgabe einer Flüssigkeit
|
|
JP3558351B2
(ja)
|
1992-12-07 |
2004-08-25 |
邦郎 辻 |
免疫抑制剤
|
|
US5449688A
(en)
|
1993-03-30 |
1995-09-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of treating chronic inflammatory diseases
|
|
US5465728A
(en)
|
1994-01-11 |
1995-11-14 |
Phillips; Michael |
Breath collection
|
|
US5741816A
(en)
|
1994-06-20 |
1998-04-21 |
Tanabe Seiyaku Co., Ltd. |
Hair-growth agent
|
|
AUPN137895A0
(en)
|
1995-02-27 |
1995-03-16 |
Clover Corporation Pty Ltd |
Composition and method
|
|
AUPN250795A0
(en)
|
1995-04-20 |
1995-05-18 |
Cultor Ltd. |
Stress regulator
|
|
ATE282625T1
(de)
|
1997-06-23 |
2004-12-15 |
Polychip Pharmaceuticals Pty |
Gaba-c-rezeptor-antagonisten zur stimulation des erinnerungsvermögens
|
|
RU2141483C1
(ru)
|
1997-07-04 |
1999-11-20 |
Небольсин Владимир Евгеньевич |
Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
|
|
IL121268A0
(en)
|
1997-07-09 |
1998-01-04 |
Dpharm Ltd |
Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
|
|
CN1283219A
(zh)
*
|
1997-10-23 |
2001-02-07 |
宝洁公司 |
脂肪酸、皂、表面活性剂体系及以其为基础的消费品
|
|
NO308197B1
(no)
|
1998-01-21 |
2000-08-14 |
Fideline |
Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
|
|
US6214875B1
(en)
|
1998-04-14 |
2001-04-10 |
Zhenhua Yang |
Anticancer effects of specific branched-chain fatty acids and related production process
|
|
WO1999058120A1
(en)
|
1998-05-08 |
1999-11-18 |
Rolf Berge |
USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
|
|
US6159485A
(en)
|
1999-01-08 |
2000-12-12 |
Yugenic Limited Partnership |
N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
|
|
US6544541B1
(en)
|
1999-06-02 |
2003-04-08 |
Cardiovascular Solutions, Inc. |
Devices and compounds for treating arterial restenosis
|
|
US7012053B1
(en)
|
1999-10-22 |
2006-03-14 |
The Procter & Gamble Company |
Fabric care composition and method comprising a fabric care polysaccharide and wrinkle control agent
|
|
US6835750B1
(en)
|
2000-05-01 |
2004-12-28 |
Accera, Inc. |
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
|
|
NO20006008L
(no)
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US6635015B2
(en)
|
2001-04-20 |
2003-10-21 |
The Procter & Gamble Company |
Body weight management system
|
|
JP2004529363A
(ja)
|
2001-06-05 |
2004-09-24 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
膵臓に基づく脂肪吸収不良障害を診断するための方法およびキット
|
|
CA2493888C
(en)
|
2001-07-27 |
2013-07-16 |
Neptune Technologies & Bioressources Inc. |
Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
|
|
FR2828487B1
(fr)
|
2001-08-09 |
2005-05-27 |
Genfit S A |
Nouveaux composes derives d'acides gras, preparation et utilisations
|
|
JP2003160486A
(ja)
|
2001-09-17 |
2003-06-03 |
Lion Corp |
経口養育毛剤及び該養育毛剤を含有する飲食品
|
|
US20030203004A1
(en)
|
2002-04-24 |
2003-10-30 |
Kelm Gary Robert |
Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
|
|
US20030203042A1
(en)
|
2002-04-24 |
2003-10-30 |
Cook Lisa Ann |
Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
|
|
US20060275294A1
(en)
|
2002-08-22 |
2006-12-07 |
Omoigui Osemwota S |
Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer
|
|
JP4286513B2
(ja)
|
2002-09-26 |
2009-07-01 |
株式会社ファンケル |
抗老化用組成物
|
|
SE0203886D0
(sv)
|
2002-12-27 |
2002-12-27 |
Ltp Lipid Technologies Provide |
Glycerolesterprodukt och dess användning
|
|
ITMI20030210A1
(it)
|
2003-02-07 |
2004-08-08 |
Res & Innovation Soc Coop A R L |
Composti endocannabinoido-simili e loro impiego
|
|
SE0303513D0
(sv)
|
2003-12-19 |
2003-12-19 |
Pronova Biocare As |
Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
|
|
WO2005099483A1
(en)
|
2004-04-16 |
2005-10-27 |
Indevex Ab |
Ingestible composition
|
|
WO2005113036A1
(en)
|
2004-05-13 |
2005-12-01 |
The Regents Of The University Of California |
Method and apparatus for glucose control and insulin dosing for diabetics
|
|
WO2005120484A1
(ja)
|
2004-06-09 |
2005-12-22 |
Kurume University |
グレリンの生理学的機能のレギュレーター
|
|
US8106093B2
(en)
|
2004-07-02 |
2012-01-31 |
Baylor Research Institute |
Glycogen or polysaccharide storage disease treatment method
|
|
CA2483675A1
(en)
|
2004-10-01 |
2006-04-01 |
Jens Peschardt |
Food bar
|
|
US8063104B2
(en)
|
2004-11-12 |
2011-11-22 |
Ucl Business Plc |
Guanidine derivatives as inhibitors of DDAH
|
|
JP2006169386A
(ja)
|
2004-12-16 |
2006-06-29 |
Showa Shell Sekiyu Kk |
潤滑グリース組成物及びそれを用いた軸受
|
|
JP2008540394A
(ja)
*
|
2005-05-04 |
2008-11-20 |
プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ |
脂肪酸組成物、即ち、ｄｈａ誘導体の医薬としての使用
|
|
US20060269495A1
(en)
|
2005-05-25 |
2006-11-30 |
Popp Karl F |
Alpha hydroxy acid compositions
|
|
US8251904B2
(en)
|
2005-06-09 |
2012-08-28 |
Roche Diagnostics Operations, Inc. |
Device and method for insulin dosing
|
|
US20100104548A1
(en)
|
2005-06-24 |
2010-04-29 |
Albert Einstein College Of Medicine Of Yeshiva University |
Modulation of amino acid metabolism in the hypothalamus
|
|
CN100579534C
(zh)
|
2005-09-30 |
2010-01-13 |
中国科学院上海药物研究所 |
S-腺苷同型半胱氨酸在制药中的应用
|
|
US20070203235A1
(en)
|
2006-02-28 |
2007-08-30 |
Rosales Francisco J |
Method for preventing or treating anemia
|
|
KR101560840B1
(ko)
|
2007-03-16 |
2015-10-15 |
가부시키가이샤 시세이도 |
주름 방지·개선제
|
|
JP2008255022A
(ja)
|
2007-04-02 |
2008-10-23 |
Kureha Corp |
抗癌性物質
|
|
NZ555163A
(en)
|
2007-05-14 |
2010-05-28 |
Fonterra Co Operative Group |
Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
|
|
US20090318369A1
(en)
|
2007-08-17 |
2009-12-24 |
Paige Lisa A |
Biomarkers for alzheimer's disease and methods using the same
|
|
DE102007055636A1
(de)
|
2007-11-21 |
2009-05-28 |
Robert Bosch Gmbh |
Medikamenten-Dosiervorrichtung zum Verabreichen eines flüssigen Medikaments
|
|
FR2931676B1
(fr)
|
2008-05-30 |
2011-01-14 |
Ceva Sante Animale |
Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
|
|
EP2316445A4
(en)
|
2008-06-11 |
2011-12-21 |
Ricom Corp |
HUMAN BETA3 ADRENERGER RECEPTOR LIGAND AND THEREOF FOOD OR PHARMACEUTICAL PREPARATION
|
|
EP2147910A1
(en)
*
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
BRPI1013856A2
(pt)
|
2009-04-20 |
2016-04-05 |
Elcelyx Therapeutics Inc |
terapias à base de ligantes de receptores quimiossensíveis
|
|
SG175401A1
(en)
|
2009-05-08 |
2011-12-29 |
Pronova Biopharma Norge As |
Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
|
|
JP2010260833A
(ja)
|
2009-05-11 |
2010-11-18 |
Daicho Kikaku:Kk |
抗自己免疫疾患剤
|
|
CA2777827C
(en)
|
2009-10-30 |
2020-08-18 |
Retrotope, Inc. |
Alleviating oxidative stress disorders with pufa derivatives
|
|
CA2785714C
(en)
|
2009-12-30 |
2016-01-26 |
Baylor Research Institute |
Anaplerotic therapy for alzheimer's disease and the aging brain
|
|
WO2011146922A2
(en)
|
2010-05-21 |
2011-11-24 |
Cytogel Pharma, Llc |
Materials and methods for treatment of inflammation
|
|
CA2803668A1
(en)
|
2010-07-01 |
2012-01-05 |
Isis Innovation Limited |
Treatment of cognitive disorders
|
|
US20120072236A1
(en)
|
2010-08-06 |
2012-03-22 |
Benjamin Atkin |
Insulin pen data recording and transmission device
|
|
CN102327368B
(zh)
|
2010-09-06 |
2013-07-24 |
成都地奥制药集团有限公司 |
三白草根茎总有效部位及其制备方法和用途
|
|
BR112013005806B1
(pt)
|
2010-09-10 |
2022-05-10 |
Epizyme, Inc |
Métodos para detectar se um indivíduo é um candidato para o tratamento com ou responsivo a um inibidor de ezh2 e usos terapêuticos do dito inibidor de ezh2
|
|
GB201020133D0
(en)
|
2010-11-26 |
2011-01-12 |
Royal Holloway & Bedford New College |
Therapeutic use of compounds
|
|
CN103547668A
(zh)
|
2010-11-27 |
2014-01-29 |
菲利普.G.罗斯 |
真菌结构体的生产方法
|
|
CN203915611U
(zh)
|
2011-02-09 |
2014-11-05 |
贝克顿·迪金森公司 |
与输注基部附接的套节及用于传送药物的传送系统
|
|
ITMI20111284A1
(it)
|
2011-07-11 |
2013-01-12 |
Giovanni Nusca |
Composizione farmaceutica.
|
|
US20140303228A1
(en)
|
2011-10-18 |
2014-10-09 |
Metabolon, Inc. |
Biomarkers for Amyotrophic Lateral Sclerosis and Methods Using the Same
|
|
JP6263124B2
(ja)
|
2012-10-17 |
2018-01-17 |
国立大学法人 岡山大学 |
化合物、その互変異性体、幾何異性体、乃至それらの塩、及びそれらの製造方法、抗菌剤、並びに感染症治療薬
|
|
ES2763352T3
(es)
|
2013-01-14 |
2020-05-28 |
Infirst Healthcare Ltd |
Composiciones de solución sólida y uso en inflamación crónica
|
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
|
WO2014179341A1
(en)
|
2013-04-29 |
2014-11-06 |
Matinas Biopharma, Inc. |
Treatment with omega-3 fatty acid compositions
|
|
JP2015010067A
(ja)
|
2013-06-28 |
2015-01-19 |
奥野製薬工業株式会社 |
肝機能改善用製剤
|
|
WO2015110977A1
(en)
|
2014-01-22 |
2015-07-30 |
Rolexi Marketing (Pty) Ltd |
Fatty acid composition and medicinal use thereof
|
|
RU2665135C2
(ru)
|
2014-03-14 |
2018-08-28 |
Олтек, Инк. |
Композиции селеноорганических соединений и способы их применения
|
|
GB201405033D0
(en)
|
2014-03-20 |
2014-05-07 |
Isis Innovation |
Combination therapy
|
|
WO2015157514A1
(en)
|
2014-04-09 |
2015-10-15 |
The Johns Hopkins University |
Ribosomal protein s15 phosphorylation mediates lrrk2 neurodegeneration in parkinson's disease
|
|
JP7171190B2
(ja)
|
2014-11-11 |
2022-11-15 |
コーニンクレッカ フィリップス エヌ ヴェ |
線源－検出器装置
|
|
US9662306B2
(en)
|
2015-01-07 |
2017-05-30 |
The United States Of America, As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of metabolic syndrome
|
|
US10022347B2
(en)
|
2015-01-07 |
2018-07-17 |
The United States Of America, As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of metabolic syndrome
|
|
US9561206B2
(en)
|
2015-01-07 |
2017-02-07 |
The United States Of America, As Represented By The Secretary Of The Navy |
Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
|
|
GB201521085D0
(en)
|
2015-11-30 |
2016-01-13 |
Biozep As |
Use
|
|
KR101830244B1
(ko)
|
2016-01-20 |
2018-02-21 |
서울대학교 산학협력단 |
신규한 헤테로방향족 고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 s1p 수용체 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
JP2017200910A
(ja)
|
2016-04-28 |
2017-11-09 |
ライオン株式会社 |
血糖値上昇抑制剤
|
|
WO2017186928A1
(en)
|
2016-04-29 |
2017-11-02 |
Curevac Ag |
Rna encoding an antibody
|
|
KR20180036318A
(ko)
|
2016-09-30 |
2018-04-09 |
경북대학교 산학협력단 |
2-아미노-2-(1-도데실-1h-1,2,3-트리아졸-4-일)프로판-1,3-디올 유도체를 유효성분으로 포함하는 퇴행성 신경질환 및 우울증 예방 또는 치료용 약학적 조성물
|
|
US10307388B2
(en)
|
2016-12-29 |
2019-06-04 |
The United States Of America As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of inflammation
|
|
US10238618B2
(en)
|
2016-12-29 |
2019-03-26 |
The United States Of America As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of anemia
|
|
WO2018157013A1
(en)
|
2017-02-24 |
2018-08-30 |
Duke University |
Compositions and methods related to sex-specific metabolic drivers in alzheimer's disease
|
|
AU2018354090B2
(en)
|
2017-10-23 |
2024-10-24 |
Epitracker, Inc. |
Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
|
|
KR102017324B1
(ko)
|
2018-04-30 |
2019-09-02 |
경북대학교 산학협력단 |
신규한 asm 활성 직접 억제 화합물 2-아미노-2-(1,2,3-트리아졸-4-일)프로판-1,3-디올 유도체 및 이의 용도
|
|
EP3793560A4
(en)
|
2018-05-16 |
2022-03-23 |
Epitracker, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF AGING-RELATED CONDITIONS
|
|
AU2019274431B2
(en)
|
2018-05-23 |
2025-03-13 |
Epitracker, Inc. |
Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
|
|
KR102087634B1
(ko)
|
2018-10-11 |
2020-03-11 |
(주)바이텍 |
항비만용 조성물
|
|
PH12021551300A1
(en)
|
2018-12-05 |
2022-03-28 |
Celagenex Res India Pvt Ltd |
Synergistic compositions of bioactive agents for optimizing cellular health
|
|
EP3908374A4
(en)
|
2019-01-09 |
2022-12-28 |
Epitracker, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
|
|
WO2020154173A1
(en)
|
2019-01-23 |
2020-07-30 |
Epitracker, Inc. |
Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
|
|
WO2020180814A1
(en)
|
2019-03-04 |
2020-09-10 |
Epitracker, Inc. |
Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain
|
|
AU2021329343A1
(en)
|
2020-08-20 |
2023-03-09 |
Epitracker, Inc. |
Compositions and methods for treatment of obesity
|
|
WO2022098572A1
(en)
|
2020-11-03 |
2022-05-12 |
Epitracker, Inc. |
Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
|
|
EP4426130A1
(en)
|
2021-11-03 |
2024-09-11 |
Epitracker, Inc. |
Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
|